JAMES A GERAGHTY
CIK 1239746 · Senior Vice President · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$581.0K
Companies
8
Total Filings
99
Lifetime Open-Market Net
-$484.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VYGR | Director | 76,588 | $3.50 | $268.1K | $113.1K | 13 | 2026-06-11 |
| FULC | Director | 90,714 | $3.45 | $313.0K | $91.6K | 8 | 2025-06-30 |
| PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Director | 0 | $13.60 | $0 | $105.7K | 13 | 2024-12-12 |
| Orchard Therapeutics plc (ORTX) Delisted | Director | 0 | $16.70 | $0 | $0 | 5 | 2024-01-24 |
| Aceragen, Inc. (IDRA) Delisted | Director | 119,543 | $7.22 | $863.7K | $817.0K | 25 | 2022-06-27 |
| JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Director | 0 | — | — | $455.0K | 13 | 2018-08-15 |
| GENZYME CORP (GENZ) Delisted | Senior Vice President | 9,845 | — | — | -$2.08M | 7 | 2011-04-06 |
| GTC BIOTHERAPEUTICS INC (GTCB) Delisted | Director | 19,163 | — | — | $8.7K | 15 | 2010-01-05 |
Recent Filings · Page 7 of 10
99 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-06-29 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-17 | VYGR | Grant (A) | — | $0 | EDGAR |
| 2016-06-15 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-16 | Aceragen, Inc. (IDRA) Delisted | Buy (P) | +10,000 | $13.4K | EDGAR |
| 2015-11-19 | JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Buy (P) | +8,000 | $94.0K | EDGAR |
| 2015-10-30 | JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Grant (A) | +2,529 | $0 | EDGAR |
| 2015-08-10 | JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Buy (P) | +12,000 | $125.5K | EDGAR |
| 2015-06-10 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-02 | JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Buy (P) | +20,550 | $172.2K | EDGAR |
| 2015-06-01 | JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Grant (A) | +461 | $3.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.